Comprehensive Analysis Of Recall Data Planned By FDA’s Device Center
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to take a closer look at its information on recalled medical devices to determine why particular recalls happen and to tailor educational efforts to manufacturers
You may also be interested in...
Hospital Groups Urge FDA To Move Quickly On Device ID Rule
A stepped-up lobbying effort by health care groups, led by hospital purchasing organization Premier, asks FDA to name a timeline for publishing its proposed rule on unique device identification, in order to get the system off the ground soon
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?